| Data | Hora | Fonte | Título | Código | Companhia |
| 14/02/2019 | 19:00 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/02/2019 | 12:47 | Edgar (US Regulatory) | Schedule 13g | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/06/2018 | 17:35 | Edgar (US Regulatory) | Amended Tender Offer Statement by Issuer (sc To-i/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/05/2018 | 17:20 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2018 | 17:39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/05/2018 | 10:11 | Edgar (US Regulatory) | Tender Offer Statement by Issuer (sc To-i) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/05/2018 | 09:30 | PR Newswire (US) | ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/05/2018 | 09:28 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/05/2018 | 07:00 | PR Newswire (US) | Amneal and Impax Complete Business Combination | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 04/05/2018 | 18:05 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 02/05/2018 | 19:19 | PR Newswire (US) | Apergy Set to Join S&P MidCap 400; 3D Systems to Join S&P SmallCap 600 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 27/04/2018 | 19:50 | PR Newswire (US) | Amneal And Impax Receive FTC Clearance For Business Combination | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 27/04/2018 | 19:30 | PR Newswire (US) | ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 13/04/2018 | 18:04 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/04/2018 | 08:33 | PR Newswire (US) | Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/04/2018 | 18:24 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 27/03/2018 | 17:05 | PR Newswire (US) | Impax Shareholders Approve Proposed Business Combination with Amneal | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 20/03/2018 | 07:04 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 14/03/2018 | 09:00 | PR Newswire (US) | Amneal Gains Approval for Erythromycin Tablets USP | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/03/2018 | 10:35 | PR Newswire (US) | Amneal Pharmaceuticals and Impax Laboratories to Present at the Barclays Global Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/03/2018 | 19:05 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/03/2018 | 09:30 | PR Newswire (US) | Amneal Launches Generic for Tamiflu® Oral Suspension | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/03/2018 | 09:00 | PR Newswire (US) | Impax Reports Fourth Quarter and Full Year 2017 Results | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 21/02/2018 | 09:51 | PR Newswire (US) | Amneal Introduces Memantine Hydrochloride Extended-Release Capsules, Generic for Namenda XR® | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 20/02/2018 | 18:05 | PR Newswire (US) | Impax Announces the Launch of an Authorized Generic Version of Solodyn® (Minocycline HCl) Extended-Release Tablets | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/02/2018 | 19:49 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 12/02/2018 | 16:17 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/02/2018 | 10:30 | PR Newswire (US) | Andrew S. Boyer Joins Amneal Pharmaceuticals as Executive Vice President, Commercial Operations | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/02/2018 | 10:00 | PR Newswire (US) | Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta® | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 01/02/2018 | 11:55 | PR Newswire (US) | Amneal Introduces Isotretinoin Capsules, USP | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |